1. Home
  2. CANF vs RVSN Comparison

CANF vs RVSN Comparison

Compare CANF & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$1.88

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Logo Rail Vision Ltd.

RVSN

Rail Vision Ltd.

N/A

Current Price

$3.35

Market Cap

7.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CANF
RVSN
Founded
1994
2016
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.9M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
CANF
RVSN
Price
$1.88
$3.35
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $7.50
N/A
AVG Volume (30 Days)
★ 25.6K
14.6K
Earning Date
09-08-2026
08-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$169.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.17
52 Week High
$10.40
$9.39

Technical Indicators

Market Signals
Indicator
CANF
RVSN
Relative Strength Index (RSI) 32.86 46.03
Support Level N/A $3.25
Resistance Level $2.27 $5.19
Average True Range (ATR) 0.09 0.26
MACD 0.01 0.03
Stochastic Oscillator 29.70 51.38

Price Performance

Historical Comparison
CANF
RVSN

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About RVSN Rail Vision Ltd.

Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.

Share on Social Networks: